Refine
Has Fulltext
- yes (35)
Is part of the Bibliography
- yes (35)
Year of publication
Document Type
- Journal article (35)
Language
- English (35) (remove)
Keywords
- ADHD (4)
- anxiety (4)
- depression (4)
- mice (4)
- emotion (3)
- hippocampus (3)
- DNA methylation (2)
- FAAH (2)
- aggression (2)
- animal behavior (2)
- behavior (2)
- chronic heart failure (2)
- endocannabinoid (2)
- genetics (2)
- glucose transporter (2)
- knockout (2)
- knockout mice (2)
- myocardial infarction (2)
- neurodevelopment (2)
- psychiatric disorders (2)
- serotonin (2)
- serotonin transporter (2)
- startle reflex (2)
- 5-HT transporter (1)
- 5-HT1A receptor (1)
- 5-HTT knockout mice (1)
- 5-HTTLPR (1)
- Abelson helper integration-1 (AHI1) (1)
- Activation (1)
- Acute tryptophan depletion (1)
- Aggressive behaviour (1)
- Anxiety-like behavior (1)
- Attention Deficit Hyperactivity Disorder (ADHD) (1)
- BDNF (1)
- BDNF Val66Met (1)
- Big Five (1)
- Bipolar disorder (1)
- CDH13 (1)
- CDH13 Expression (1)
- CDH13 mRNA (1)
- CRISPR-Cas Systems (1)
- Cadherin (CDH13) (1)
- Cadherin-13 (CDH13) (1)
- Chronic stress (1)
- Cytokines (1)
- Depression (1)
- GABA (1)
- GAD1 (1)
- GLUT3 (1)
- Human CDH13 (1)
- Induced Pluripotent Stem Cells (1)
- Insensitivity (1)
- Interferon-alpha (1)
- Knock-out mice (1)
- LPS (1)
- Long-term depression (1)
- Major depression (1)
- Messenger-RNA (1)
- Mice (1)
- Mood disorders (1)
- Mouse-brain (1)
- Neuronal plasticity (1)
- Physiological functions (1)
- RNA expression (1)
- Rat-brain (1)
- Restraint stress (1)
- S-HT (1)
- SERT (1)
- SLC2A3 (1)
- Schizophrenie (1)
- Serotonin (1)
- Serotonin transporter (1)
- Serotonin transporter polymorphism (1)
- Sert-deficient mice (1)
- Toll-like receptor 4 (TLR4) (1)
- Tryptophan hydroxylase-2 (Tph2) (1)
- Western diet (1)
- Xenopus laevis oocytes (1)
- adolescence (1)
- adversity (1)
- affective disorders (1)
- affective state (1)
- aggressiveness (1)
- aging (1)
- agreeableness (1)
- amino acid analysis (1)
- animal performance (1)
- antidepressant (1)
- antidepressants (1)
- anxiety disorders (1)
- anxiety like (1)
- anxiety-like behavior (1)
- astrocytes (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- attentional bias (1)
- autism-like behavior (1)
- autoinhibition (1)
- brain development (1)
- brain disorders (1)
- cadherins (1)
- cell membranes (1)
- chronic stress (1)
- congenital heart-deffects (1)
- coping with challenge (1)
- copy number variation (1)
- copy-number variation (1)
- corticotropin releasing factor (1)
- crystal structure (1)
- deficient mice (1)
- diet (1)
- dorsal raphe nucleus (1)
- emotional behavior (1)
- emotional information (1)
- energy expenditure (1)
- energy metabolism (1)
- executive function training (1)
- executive functions (1)
- expression (1)
- extinction (1)
- fear (1)
- fear learning (1)
- female (1)
- gene-by-environment interaction (1)
- geneexpression (1)
- genetic variants (1)
- glia (1)
- glucose (1)
- glucose tolerance (1)
- heterosis (1)
- heterozygote (1)
- hiPSC (1)
- human induced pluripotent stem cell (hiPSC) (1)
- humans (1)
- iPSC (1)
- immediate early genes (1)
- immediate-early gene (1)
- in vivo (1)
- inflammation (1)
- inflammatory diseases (1)
- insulin receptor (1)
- judgement bias (1)
- knock-out mice (1)
- laboratory environment (1)
- lacking (1)
- learning (1)
- learning curves (1)
- locomotor activity (1)
- long-term potentiation (1)
- major depressive disorder (MDD) (1)
- maternal separation (1)
- mechanismofaction (1)
- median and dorsal raphe (1)
- membrane potential (1)
- membrane proteins (1)
- mental disorders (1)
- middle aged (1)
- monoamine transporters (1)
- mouse (1)
- mouse model (1)
- myelination (1)
- nervous system (1)
- neurodegeneration (1)
- neurodevelopmental disorders / genetics (1)
- neuroinflammation (1)
- neuronal plasticity (1)
- neuropsychiatric disorders (1)
- nitricoxidesynthase (1)
- nucleus (1)
- obesity (1)
- oxidative stress (1)
- panic disorder (1)
- plasticity (1)
- prefrontal cortex (1)
- primary response genes (1)
- promoter region (1)
- rare mendelian disorders (1)
- rat brain (1)
- receptors (1)
- regulatory T cells (1)
- response inhibition (1)
- serotonin deficiency (1)
- serotonin receptors (1)
- serotonin transporter deficient mice (1)
- serotonin transporter gene (1)
- serotonin-specific neurons (1)
- sialic acid (1)
- sialyltransferase (1)
- social experience (1)
- spatial memory (1)
- stem cells (1)
- swim test (1)
- synapse formation (1)
- telomere length (1)
- transporter gene SLC2A3 (1)
- treatment guidelines (1)
- tryptophan (1)
- tryptophan hydroxylase 2 (1)
- tryptophan hydroxylase-2 (1)
- working memory (1)
Institute
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (35) (remove)
Copy number variants of SLC2A3, which encodes the glucose transporter GLUT3, are associated with several neuropsychiatric and cardiac diseases. Here, we report the successful reprogramming of peripheral blood mononuclear cells from two SLC2A3 duplication and two SLC2A3 deletion carriers and subsequent generation of two transgene-free iPSC clones per donor by Sendai viral transduction. All eight clones represent bona fide hiPSCs with high expression of pluripotency genes, ability to differentiate into cells of all three germ layers and normal karyotype. The generated cell lines will be helpful to enlighten the role of glucometabolic alterations in pathophysiological processes shared across organ boundaries.
Sodium-glucose transporters (SGLT) belong to the solute carrier 5 family, which is characterized by sodium dependent transport of sugars and other solutes. In contrast, the human SGLT3 (hSGLT3) isoform, encoded by SLC5A4, acts as a glucose sensor that does not transport sugar but induces membrane depolarization by Na\(^{+}\) currents upon ligand binding. Whole-exome sequencing (WES) of several extended pedigrees with high density of attention-deficit/hyperactivity disorder (ADHD) identified a triplet ATG deletion in SLC5A4 leading to a single amino acid loss (ΔM500) in the hSGLT3 protein imperfectly co-segregating with the clinical phenotype of ADHD. Since mutations in homologous domains of hSGLT1 and hSGLT2 were found to affect intestinal and renal function, respectively, we analyzed the functional properties of hSGLT3[wt] and [ΔM500] by voltage clamp and current clamp recordings from cRNA-injected Xenopus laevis oocytes.
The cation conductance of hSGLT3[wt] was activated by application of glucose or the specific agonist 1-desoxynojirimycin (DNJ) as revealed by inward currents in the voltage clamp configuration and cell depolarization in the current clamp mode. Almost no currents and changes in membrane potential were observed when glucose or DNJ were applied to hSGLT3[ΔM500]-injected oocytes, demonstrating a loss of function by this amino acid deletion in hSGLT3. To monitor membrane targeting of wt and mutant hSGLT3, fusion constructs with YFP were generated, heterologously expressed in Xenopus laevis oocytes and analyzed for membrane fluorescence by confocal microscopy. In comparison to hSGLT3[wt] the fluorescent signal of mutant [ΔM500] was reduced by 43% indicating that the mutant phenotype might mainly result from inaccurate membrane targeting. As revealed by homology modeling, residue M500 is located in TM11 suggesting that in addition to the core structure (TM1-TM10) of the transporter, the surrounding TMs are equally crucial for transport/sensor function.
In conclusion, our findings indicate that the deletion [ΔM500] in hSGLT3 inhibits membrane targeting and thus largely disrupts glucose-induced sodium conductance, which may, in interaction with other ADHD risk-related gene variants, influence the risk for ADHD in deletion carriers.
Nonalcoholic fatty liver disease, induced by a Western diet (WD), evokes central and peripheral inflammation that is accompanied by altered emotionality. These changes can be associated with abnormalities in social behaviour, hippocampus-dependent cognitive functions, and metabolism. Female C57BL/6J mice were fed with a regular chow or with a WD containing 0.2% of cholesterol and 21% of saturated fat for three weeks. WD-treated mice exhibited increased social avoidance, crawl-over and digging behaviours, decreased body-body contacts, and hyperlocomotion. The WD-fed group also displayed deficits in hippocampal-dependent performance such as contextual memory in a fear conditioning and pellet displacement paradigms. A reduction in glucose tolerance and elevated levels of serum cholesterol and leptin were also associated with the WD. The peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1a) mRNA, a marker of mitochondrial activity, was decreased in the prefrontal cortex, hippocampus, hypothalamus, and dorsal raphe, suggesting suppressed brain mitochondrial functions, but not in the liver. This is the first report to show that a WD can profoundly suppress social interactions and induce dominant-like behaviours in naïve adult mice. The spectrum of behaviours that were found to be induced are reminiscent of symptoms associated with autism, and, if paralleled in humans, suggest that a WD might exacerbate autism spectrum disorder.
Genetic and molecular mechanisms that play a causal role in mental illnesses are challenging to elucidate, particularly as there is a lack of relevant in vitro and in vivo models. However, the advent of induced pluripotent stem cell (iPSC) technology has provided researchers with a novel toolbox. We conducted a systematic review using the PRISMA statement. A PubMed and Web of Science online search was performed (studies published between 2006–2020) using the following search strategy: hiPSC OR iPSC OR iPS OR stem cells AND schizophrenia disorder OR personality disorder OR antisocial personality disorder OR psychopathy OR bipolar disorder OR major depressive disorder OR obsessive compulsive disorder OR anxiety disorder OR substance use disorder OR alcohol use disorder OR nicotine use disorder OR opioid use disorder OR eating disorder OR anorexia nervosa OR attention-deficit/hyperactivity disorder OR gaming disorder. Using the above search criteria, a total of 3515 studies were found. After screening, a final total of 56 studies were deemed eligible for inclusion in our study. Using iPSC technology, psychiatric disease can be studied in the context of a patient’s own unique genetic background. This has allowed great strides to be made into uncovering the etiology of psychiatric disease, as well as providing a unique paradigm for drug testing. However, there is a lack of data for certain psychiatric disorders and several limitations to present iPSC-based studies, leading us to discuss how this field may progress in the next years to increase its utility in the battle to understand psychiatric disease.
Aggression and deficient cognitive control problems are widespread in psychiatric disorders, including major depressive disorder (MDD). These abnormalities are known to contribute significantly to the accompanying functional impairment and the global burden of disease. Progress in the development of targeted treatments of excessive aggression and accompanying symptoms has been limited, and there exists a major unmet need to develop more efficacious treatments for depressed patients. Due to the complex nature and the clinical heterogeneity of MDD and the lack of precise knowledge regarding its pathophysiology, effective management is challenging. Nonetheless, the aetiology and pathophysiology of MDD has been the subject of extensive research and there is a vast body of the latest literature that points to new mechanisms for this disorder. Here, we overview the key mechanisms, which include neuroinflammation, oxidative stress, insulin receptor signalling and abnormal myelination. We discuss the hypotheses that have been proposed to unify these processes, as many of these pathways are integrated for the neurobiology of MDD. We also describe the current translational approaches in modelling depression, including the recent advances in stress models of MDD, and emerging novel therapies, including novel approaches to management of excessive aggression, such as anti-diabetic drugs, antioxidant treatment and herbal compositions.